XML 20 R30.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
Restructuring (Tables)
9 Months Ended
Nov. 30, 2019
Restructuring  
Schedule of restructuring-related costs

For the thirteen week period ended November 30, 2019, the Company incurred total restructuring-related costs of $25,275, which are included as a component of SG&A. These costs are as follows:

Retail Pharmacy

Pharmacy

    

 segment

    

Services segment

    

Total

Restructuring-related costs

Severance and related costs associated with ongoing reorganization efforts (a)

 

$

10,866

 

$

6,454

 

$

17,320

Non-executive retention costs associated with the March 2019 reorganization (b)

 

862

 

406

 

1,268

Professional and other fees relating to restructuring activities (c)

 

6,687

 

 

6,687

Total restructuring-related costs

 

$

18,415

 

$

6,860

 

$

25,275

For the thirty-nine week period ended November 30, 2019, the Company incurred total restructuring-related costs of $93,770, which are included as a component of SG&A. These costs are as follows:

Retail Pharmacy

Pharmacy

    

 segment

    

Services segment

    

Total

Restructuring-related costs

Severance and related costs associated with ongoing reorganization efforts (a)

 

$

44,008

 

$

8,769

 

$

52,777

Non-executive retention costs associated with the March 2019 reorganization (b)

 

8,191

 

3,828

 

12,019

Professional and other fees relating to restructuring activities (c)

 

26,652

 

2,322

 

28,974

Total restructuring-related costs

 

$

78,851

 

$

14,919

 

$

93,770

Schedule of restructuring-related liabilities

Severance and related

Professional and

    

costs (a)

    

Retention costs (b)

    

other fees (c)

    

Total

Balance at March 2, 2019

$

 

$

4,704

 

$

 

$

4,704

Additions charged to expense 

 

27,076

 

6,664

 

9,610

 

43,350

Cash payments

 

(4,653)

 

(242)

 

(9,610)

 

(14,505)

Balance at June 1, 2019

$

22,423

 

$

11,126

 

$

 

$

33,549

Additions charged to expense 

 

8,381

4,087

12,677

25,145

Cash payments

 

(4,580)

(11,200)

(6,768)

(22,548)

Balance at August 31, 2019

$

26,224

$

4,013

$

5,909

$

36,146

Additions charged to expense 

17,320

1,268

6,687

25,275

Cash payments

(5,036)

(5,088)

(10,124)

Balance at November 30, 2019

 

$

38,508

 

$

5,281

 

$

7,508

 

$

51,297

(a)– Severance and related costs reflect severance accruals, executive search fees, outplacement services and other similar charges associated with ongoing reorganization efforts.
(b)– As part of its March 2019 reorganization, the Company incurred costs with the implementation of a retention plan for certain of its key associates.
(c)– Professional and other fees include costs incurred in connection with the identification and implementation of transformation initiatives associated with restructuring activities.